Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
Integrating multimodal behavioral therapy into temporomandibular disorders management: A randomized
Sunil Kumar Vaddamanu1, Abdulkhaliq Ali F Alshadidi2, Lujain Ibrahim N Aldosari3
1Department of Allied Dental Health Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia; Health and Medical Research Centre, King Khalid University, Abha, Saudi Arabia.
Background:
Temporomandibular disorders (TMD) involve physical symptoms like pain and jaw dysfunction, and psychosocial factors including anxiety and depression, evaluated using Axis II of the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). This study assessed a structured, multicomponent behavioral therapy program-integrating pain neuroscience education, cognitive-behavioral therapy (CBT), relaxation techniques, and electromyographic biofeedback-as an adjunct to standard TMD care.
Methods:
In a randomized controlled trial, 120 TMD patients (ages 18-65) diagnosed via DC/TMD were assigned either to an 8-week behavioral therapy program (n = 60) or standard care with analgesics and physical therapy (n = 60). Outcomes measured at baseline, post-treatment (8 weeks), and 6-month follow-up included pain intensity (Visual Analog Scale, VAS; primary), jaw function (maximum mouth opening, MMO, and Jaw Functional Limitation Scale-20, JFLS-20), pain-related disability and characteristic pain intensity (Graded Chronic Pain Scale, GCPS), psychological distress (Generalized Anxiety Disorder-7 [GAD-7] and Patient Health Questionnaire-9 [PHQ-9]), and pain catastrophizing (Pain Catastrophizing Scale, PCS). Intervention reporting follows the TIDieR guideline.
Results:
Behavioral therapy participants showed greater reductions in pain intensity (VAS mean difference 1.8 points at 8 weeks [Cohen's d = 1.2] and 2.5 points at 6 months [Cohen's d = 1.4]), improved jaw function (MMO mean difference 6.6 mm at 8 weeks and 7.3 mm at 6 months; Cohen's d ≈ 0.92-1.12), and reduced anxiety (GAD-7) and depression (PHQ-9) (Cohen's d ≈ 0.62-0.65). Improvements were sustained at 6 months across all outcomes.
Conclusion:
Behavioral therapy may enhance outcomes in TMD management when added to standard care, supporting further exploration of multidisciplinary approaches.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Rational Emotive Behavior Therapy
DC Generator
DC Battery